Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
12.37
+1.08 (9.57%)
At close: Nov 9, 2026, 4:00 PM EST
12.42
+0.05 (0.40%)
Pre-market: Nov 10, 2026, 7:01 AM EST

Ginkgo Bioworks Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8334725213,3342,85612,355
Market Cap Growth
29.67%-9.39%-84.36%16.75%-76.89%-
Enterprise Value
9454333512,6881,61810,698
Last Close Price
12.378.319.8267.6067.60332.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
6.372.782.3013.265.9839.37
PB Ratio
2.020.930.733.041.657.88
P/TBV Ratio
2.361.050.813.451.838.45

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
7.232.551.5410.693.3934.09

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.010.870.650.220.260.02
Net Debt / Equity Ratio
0.280.03-0.13-0.64-0.50-0.97
Net Debt / EBITDA Ratio
-0.47-0.060.221.040.410.85
Net Debt / FCF Ratio
-0.64-0.100.252.102.874.92
Asset Turnover
0.120.140.150.120.210.23
Inventory Turnover
----51.9020.30
Quick Ratio
4.514.665.455.878.0912.51
Current Ratio
4.724.925.626.118.3812.79
Return on Equity (ROE)
-58.22%-51.08%-60.34%-63.02%-127.52%-180.29%
Return on Assets (ROA)
-15.76%-15.42%-19.67%-21.82%-59.54%-83.23%
Return on Capital Employed (ROCE)
-30.60%-30.10%-37.70%-48.90%-92.80%-94.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-33.44%-66.22%-104.94%-26.78%-73.72%-14.81%
FCF Yield
-20.83%-37.84%-73.31%-10.09%-10.66%-2.51%
Buyback Yield / Dilution
-11.06%-6.87%-6.76%-15.75%-23.48%-6.71%
SEC Filings: 10-K · 10-Q